Dr. Colm Moran has been appointed chief regulatory officer at Alltech, a global agri-business with more than 5,000 staff and customers in over 120 countries.

Moran has worked with Alltech for more than 20 years, most recently serving as director of European regulatory affairs and as chair of Alltech’s crisis management team.

Dr. Mark Lyons, president and CEO of Alltech said: “Alltech’s regulatory strategy is moving into new strength under Colm’s leadership.

“This positions Alltech firmly at the leading edge in delivering innovation to our customers.”

New appointment

Moran has worked in the feed industry for 23 years and has extensive experience in zootechnical studies for registration of feed additives for livestock and poultry species.

Dr. Colm Moran. Image source: Alltech

He graduated with a bachelor’s degree in biotechnology from University of Wales, Cardiff, and three masters degrees in food biotechnology, food regulatory affairs, and brewing and distilling — from University of Strathclyde, University of Ulster/University College Dublin (UCD), and Heriott-Wyatt University, respectively.

He also has a PhD in fermentation microbiology from University of Plymouth.

Moran has published more than 70 peer-reviewed articles in his subject area. He has received two international patents and has presented at numerous international conferences. He is based in Marseille, France.

Moran serves on the board of directors for the International Feed Industry Federation (IFIF).

Alltech

Founded in 1980 by Irish entrepreneur and scientist Dr. Pearse Lyons, Alltech delivers sustainable solutions for agriculture.

Its portfolio of products and services aims to improve the health and performance of plants and animals, resulting in better nutrition and a decreased environmental impact.

The family-owned company produces specialty ingredients, pre-mix supplements, feed and biologicals, backed by science.

Headquartered just outside of Lexington, Kentucky in the US, Alltech serves customers in more than 120 countries, has five bioscience centres, and operates more than 80 manufacturing facilities across the globe.